Table 1.
Association of AGAP2-AS1 expression with clinicopathological variables in EOC patients
| Variable | Low AGAP2-AS1 | High AGAP2-AS1 | P |
|---|---|---|---|
| Expression, n (%) | Expression, n (%) | ||
| n=40 | n=40 | ||
| Age (years) | |||
| <50 | 13 | 12 | 0.809 |
| ≥50 | 27 | 28 | |
| Histological subtype | |||
| Serous | 39 | 28 | 0.001 |
| Other | 1 | 12 | |
| FIGO stage | |||
| I-II | 7 | 15 | 0.045 |
| III-IV | 33 | 25 | |
| Histological grade | |||
| High | 39 | 31 | 0.007 |
| Low | 1 | 9 | |
| Residual tumor diameter (cm) | 0.396 | ||
| <1 | 36 | 38 | |
| ≥1 | 4 | 2 | |
| Lymph node metastasis | |||
| Absent | 20 | 29 | 0.039 |
| Present | 20 | 11 | |
| CA125 level (U/ml) | |||
| <600 | 18 | 20 | 0.654 |
| ≥600 | 22 | 20 | |
| Ascites | |||
| <100 | 21 | 24 | 0.499 |
| ≥100 | 19 | 16 |
NOTE: The median value of AGAP2-AS1 expression was used as a cut-off for the low/high AGAP2-AS1 expression groups.